Use of antibodies neutralizing epithelial cell infection to diagnose patients at risk for CMV Disease after transplantation

Our results indicate that antibodies neutralizing epithelial cell infection may have an important role in long-term protection. Quantification of antibodies neutralizing epithelial cells, in addition to the T-cell response, may be useful for identifying patients with lower risk for CMV disease.